rhodamine 123 has been researched along with Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bussel, J; Cunningham-Rundles, S; Gorlick, R; Levy, AS; Mazza, B; Simm, M | 1 |
Cavalcanti, GB; de Almeida Dobbin, J; Klumb, CE; Maia, RC; Pinto de Faria, G; Scheiner, MA; Vasconcelos, FC | 1 |
2 other study(ies) available for rhodamine 123 and Syndrome
Article | Year |
---|---|
High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoimmune Diseases; Cell Culture Techniques; Female; Fluorescent Dyes; Humans; Lymphocytes; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Syndrome; Thrombocytopenia | 2002 |
Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow Cells; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Dyes; Genes, MDR; Humans; K562 Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Rhodamine 123; Syndrome; Time Factors; Tumor Suppressor Protein p53 | 2004 |